More about Quidel. Though a little dated, this article from the Columbus Dispatch gives you some idea of the capability of the Athens plant and its key role in the whole Quidel company.
Now that the demand for Covid testing is declining, they probably are putting more of their resources into producing the myriad of diagnostic kits they make for other infectious diseases. Many of these kits were develop in Athens by Quidel scientists who pioneered this type of DNA-based diagnostic testing. The old Diagnostic Hybrid company, now part of Quidel, was a spin off from the Ohio University Innovation Center.
Key Quote from the article:
"The 110,000-square-foot plant in Athens has the capacity to produce about a half-million COVID-19 tests per week. Originally, the company expected to be able to do only 150,000 tests per week, said Geoff Morgan, the Athens plant manager."
The full article is here:
https://www.dispatch.com/story/news/technology/2020/09/13... /